Kisspeptin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of Kisspeptin is very short for Kisspeptin-10; longer for Kisspeptin-54. This means dosing daily or pulsatile dosing is typical to maintain stable levels. The half-life directly affects how long Kisspeptin remains active and influences optimal injection timing.
What Is the Half-Life of Kisspeptin?
The half-life of Kisspeptin is very short for Kisspeptin-10; longer for Kisspeptin-54. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer Kisspeptin to maintain therapeutic blood levels.
What Does Kisspeptin's Half-Life Mean for Dosing?
With a half-life of very short for Kisspeptin-10; longer for Kisspeptin-54, Kisspeptin requires dosing daily or pulsatile dosing to maintain stable levels. The standard dosage of 100-200 mcg subcutaneous via subcutaneous injection, intranasal (experimental) accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, Kisspeptin reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For Kisspeptin, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject Kisspeptin?
Optimal timing depends on your research goals. A half-life of very short for Kisspeptin-10; longer for Kisspeptin-54 means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (daily or pulsatile dosing) for more stable levels throughout the day.
How Does Kisspeptin's Half-Life Compare to Similar Peptides?
Kisspeptin is a Neuroendocrine peptide, GPR54 receptor agonist. Its half-life of very short for Kisspeptin-10; longer for Kisspeptin-54 positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your Kisspeptin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Kisspeptin.
Open Calculator →Bottom Line: Kisspeptin Half-Life and Dosing
Kisspeptin has a half-life of very short for Kisspeptin-10; longer for Kisspeptin-54, supporting the standard protocol of 100-200 mcg subcutaneous dosed daily or pulsatile dosing over single dosing for IVF protocols; multi-week protocols undefined.
Read our Kisspeptin dosage guide for complete protocol details.
Complete Guide
Kisspeptin : Benefits, Dosage, Side Effects & Research
Related Reading
- Kisspeptin Dosage Guide
- Kisspeptin Benefits
- Kisspeptin Side Effects
- Kisspeptin Stacking Guide
- Kisspeptin Cycle Guide
- Kisspeptin Research
Research-Grade Sourcing
If you're going to research Kisspeptin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Kisspeptin?
Kisspeptin (Kisspeptin-10/Kisspeptin-54) is a Neuroendocrine peptide, GPR54 receptor agonist. Endogenous neuropeptide encoded by KISS1 gene; master regulator of the reproductive hormone axis. It is researched for reproductive hormone stimulation, fertility enhancement, egg maturation induction, ovulation triggering, testicular function support.
What is the recommended Kisspeptin dosage?
Common dosages: 100-200 mcg subcutaneous administered daily or pulsatile dosing via subcutaneous injection, intranasal (experimental). Cycle length: single dosing for IVF protocols; multi-week protocols undefined. Half-life: very short for Kisspeptin-10; longer for Kisspeptin-54. Use our peptide calculator for exact reconstitution math.
What are the side effects of Kisspeptin?
Minimal in early human studies. Potential headaches, flushing, or autonomic symptoms. Theoretical concerns for hormonal imbalance with chronic use.
Is Kisspeptin safe?
Kisspeptin has shown a preliminary safety profile in research. Not FDA-approved. Investigational use only. All research should follow appropriate safety protocols.